| Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704) |
|---|
| 06/15/2011 | CN1832948B 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 06/08/2011 | EP1479397B1 2,4,6-triamino-1,3,5-triazine derivative |
| 06/08/2011 | EP1300407B2 Carbamates derived from arylalkylamines |
| 06/08/2011 | CN102089304A Quinuclidine derivatives as muscarinic M3 receptor antagonists |
| 06/01/2011 | EP2326633A1 Compounds for the treatment of hepatitis c |
| 06/01/2011 | EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/26/2011 | US20110124678 Treatment with alpha 7-selective ligands |
| 05/26/2011 | US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |
| 05/25/2011 | EP2325175A1 2,4-diaminopyrimidine compound |
| 05/25/2011 | EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
| 05/25/2011 | CN102070631A Quaternary ammonium salt of penehyclidine optical isomer, medicinal composition and medical application thereof |
| 05/25/2011 | CN101160308B Pharmacetically acceptable salt with decoquinate ketone compound with improved medicine performance |
| 05/24/2011 | US7947854 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds |
| 05/24/2011 | CA2490888C Diaminopyrimidinecarboxamide derivative |
| 05/19/2011 | WO2011058427A1 Palonosetron metabolites |
| 05/19/2011 | US20110118305 Compounds |
| 05/19/2011 | US20110118223 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/19/2011 | US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases |
| 05/18/2011 | EP2322179A1 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders |
| 05/18/2011 | EP2321310A1 Cinchona-based bifucntional organocatalysts and method for preparing chiral hemiesters using the same |
| 05/17/2011 | US7943773 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| 05/12/2011 | WO2011001400A3 Processes for the preparation of form i and form ii of palonosetron hydrochloride |
| 05/12/2011 | US20110112119 Azabicyclooctyl-quinazolone derivatives useful as nicotinic acetylcholine receptor modulators |
| 05/05/2011 | WO2011053706A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/05/2011 | US20110105548 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 05/05/2011 | US20110104315 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 05/05/2011 | CA2779108A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/04/2011 | CN102040602A 毒蕈碱性乙酰胆碱受体拮抗剂 Muscarinic acetylcholine receptor antagonist |
| 05/04/2011 | CN102040601A 1-N-(1-azabicyalo(2,2,2) octane ether compound and application thereof |
| 05/04/2011 | CN102040600A Substituted 1-azabicyclo (2, 2, 2) octane quaternary ammonium salt and use thereof |
| 05/04/2011 | CN102040599A Pharmaceutical application of bicyclo-(2,2,2) octane pentenyl ester |
| 05/04/2011 | CN102040598A Pharmacy application of 1-aza-bicyclo (2, 2, 2) octane amyl |
| 05/03/2011 | CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 05/03/2011 | CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers |
| 04/28/2011 | WO2011049155A1 Process for production of quinuclidine compounds |
| 04/28/2011 | WO2011048607A1 Processes for the preparation of solifenacin or a salt thereof |
| 04/27/2011 | EP2314586A1 2-Acylaminothiazole derivative or salt thereof |
| 04/27/2011 | EP2313404A1 Quinuclidine carbonate derivatives and medicinal composition thereof |
| 04/26/2011 | CA2491506C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/21/2011 | US20110092695 Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance |
| 04/20/2011 | EP2311807A1 Compounds and composition as protein kinase inhibitors |
| 04/20/2011 | EP2310387A2 A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms |
| 04/20/2011 | CN102026992A Novel HSP inhibitory carbazole derivatives, compositions containing same, and use thereof |
| 04/19/2011 | US7928238 1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors |
| 04/14/2011 | WO2011043480A1 Homocysteine synthase inhibitor |
| 04/14/2011 | US20110086818 Methods, compositions, and kits for treating pain and pruritus |
| 04/13/2011 | EP2308876A1 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists |
| 04/13/2011 | EP2308875A1 Fused bicycloheterocycle substituted quinuclidine derivatives as .alpha.7 nAChR modulators |
| 04/13/2011 | EP2307408A1 Azabicyclooctyl-quinazolone derivatives useful as nicotinic acetylcholine receptor modulators |
| 04/13/2011 | CN101384549B Pyrrole derivative or salt thereof |
| 04/13/2011 | CN101029049B Use of recovered and reutilized quinine derivative derivative ligand in synthesizing paclitaxel and polyene paclitaxel sided chain |
| 04/12/2011 | US7923559 7-(3-pyridyl)-1,7-diazaspiro[4.4]nonane; mania, anxiety, dyslexia, schizophrenia, depression, obsessive-compulsive disorders, Tourette's syndrome |
| 04/06/2011 | EP2305684A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 04/06/2011 | EP2305676A1 Synthesis of solifenacin monosuccinate |
| 04/06/2011 | EP2305675A1 Indazoles, Benzothiazoles, and Benzoisothiazoles, and preparation and uses thereof |
| 04/06/2011 | EP2305671A1 Thiophene and thiazole derivatives as CHK1 inhibitors |
| 04/06/2011 | EP1519939B9 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 04/05/2011 | CA2475432C 2,4,6-triamino-1,3,5-triazine derivative |
| 03/31/2011 | US20110077405 Process for preparation of enantiomerically pure (s)-1-phenyi-1,2,3,4- tetrahydroisoquinoline |
| 03/30/2011 | EP2300464A1 Quinuclidine derivatives as muscarinic m3 receptor antagonists |
| 03/30/2011 | EP2217597B1 Quinuclidin-4-ylmethyl 1h-indole-3-carboxylate derivatives as alpha 7 nicotinic acetylcholine receptor ligands for the treatment of alzheimer's disease |
| 03/30/2011 | CN101993444A Method to synthesize quinuclidine hydrochloride |
| 03/24/2011 | US20110071189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071188 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071187 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/17/2011 | US20110065922 Process for Preparation Of Solifenacin and/or the Pharmaceutically Acceptable Salts Thereof of High Pharmaceutical Purity |
| 03/17/2011 | US20110065746 Composition of solifenacin or salt thereof for use in solid formulation |
| 03/16/2011 | EP2295402A2 Antibacterial agents |
| 03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |
| 03/09/2011 | EP2291374A1 Process for preparation of solifenacin and/or the pharmaceutically acceptable salts thereof of high pharmaceutical purity |
| 03/09/2011 | EP1732920B1 Thiophene derivatives as chk 1 inhibitors |
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/01/2011 | US7897617 Quinuclidine derivatives and medicinal compositions containing the same |
| 02/24/2011 | US20110046110 Quinolines and related analogs as sirtuin modulators |
| 02/22/2011 | US7893087 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/16/2011 | EP2282991A2 Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives |
| 02/09/2011 | EP1405638B1 Pharmaceutical composition comprising quinuclidin-3'-yl 1-phenyl-1,2,3,4,-tetrahydroisoquinoline-2-carboxylate for treatment of interstitial cystitis and/or abacterial prostatitis |
| 02/09/2011 | CN1824663B Preparation method of pentethyl quinamidine optical isomer |
| 02/09/2011 | CN101967143A Ligands for G-protein coupled receptors |
| 02/08/2011 | US7884113 Eating and metabolism disorders; obesity; metabolism disorders; central nervous system disorders; analgesics; antiinflammatory agents; cognition activators |
| 02/03/2011 | WO2011013095A1 Processes for the preparation of palonosetron |
| 02/03/2011 | US20110028725 Preparation and Use of Alkylating Agents |
| 02/01/2011 | US7879879 Biphenyl derivatives |
| 02/01/2011 | US7879874 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/01/2011 | CA2494091C Substituted furo [2,3-b| pyridine derivatives |
| 02/01/2011 | CA2481055C Combinations of quinolinone derivatives and 5-fu or cpt 11 |
| 01/27/2011 | US20110021594 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof |
| 01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
| 01/26/2011 | EP2094694B1 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists |
| 01/25/2011 | US7875630 reacting exo-8-methyl-8-azabicyclo[3.2.1]octan-3-thiol with mutilin 14-methanesulfonyloxyacetate in the presence of a tetra-n-butylammonium hydrogensulfate phase transfer catalyst, 4-methyl-2-pentanone, and aqueous NaOH to form mutilin 14-(exo-8-methyl-8-azabicyclo[3.2. 1]oct-3-ylsulfanyl)-acetate |
| 01/25/2011 | CA2599158C Pharmaceutical agent comprising solifenacin |
| 01/19/2011 | EP2273992A1 Quenolines and related analogs as sirtuin modulators |
| 01/19/2011 | EP1656375B1 Novel quinuclidine derivatives and their pharmaceutical use |
| 01/19/2011 | CN101948468A Preparation method of quinine hydrochloride |
| 01/13/2011 | WO2011003624A1 A process for the preparation and purification of solifenacin salts |
| 01/12/2011 | EP1987006B1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 01/12/2011 | EP1802616B1 Novel azabicyclic aryl derivatives and their medical use |
| 01/12/2011 | CN101314601B Preparation process of high-purity palonosetron Hcl |